캘리포니아주 퍼시픽 바이오사이언시스(Pacific Biosciences of California, Inc.)
MX ˙ BMV ˙ US69404D1081
SecurityMX:PACB / Pacific Biosciences of California, Inc.
InstitutionKoa Wealth Management, LLC
Latest Disclosed Ownership120,000 shares
Latest Disclosed Value $ 158,400
Koa Wealth Management, LLC ownership in PACB / Pacific Biosciences of California, Inc.

On April 29, 2026 - Koa Wealth Management, LLC filed a 13F-HR form disclosing ownership of 120,000 shares of Pacific Biosciences of California, Inc. (MX:PACB) valued at $158,400 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 120,000 shares of Pacific Biosciences of California, Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-29 2026-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 120,000 0 0.00 158 -29.46 0.1145
2026-01-29 2025-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 120,000 0 0.00 224 46.41 0.1541
2025-10-28 2025-09-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 120,000 0 0.00 154 3.38 0.1139
2025-07-29 2025-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 120,000 0 0.00 149 4.96 0.1182
2025-05-12 2025-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 120,000 0 0.00 142 -35.62 0.1144
2025-01-23 2024-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 120,000 0 0.00 220 7.35 0.1795
2024-11-06 2024-09-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 120,000 0 0.00 204 24.39 0.1576
2024-07-23 2024-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 120,000 0 0.00 164 -63.56 0.1389
2024-05-07 2024-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 120,000 0 0.00 450 -61.77 0.4056
2024-05-07 2023-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 120,000 120,000 1,177 1.1622
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.